Rasaense ea ka sehloohong oa MingCeler

DR.WUNgaka Guangming Wu, PhD

Dr. Guangming Wu, moprofesa oa Guangzhou Bio-land Laboratory, o sebelitse e le motlatsi oa lipatlisiso kapa mosebetsi-'moho le eena New England Medical Animal Center, Brown University, Univesithi ea Missouri-Columbia, Temple University School of Medicine, le mekhatlo e meng e tsebahalang ea machaba ea lipatlisiso. .Ka 2004, o ile a ikopanya le Max Planck Institute for Molecular Biology (MPI) Jeremane, moo a ileng a sebetsa le Prof. Hans R. Schöler (Setho sa Jeremane National Academy of Sciences) mabapi le nts'etsopele ea li-embryo tsa mouse le mekhoa ea lisele tsa stem.

Dr. Wu o 'nile a sebetsa ka mekhoa ea limolek'hule ea batho, porcine, bovine, le mouse oocyte le tsoelo-pele ea pele ea embryonic, le ho thehoa ha totipotency le pluripotency ka lilemo tse fetang 30,' me o tseba hantle mekhoa e sa tšoaneng ea embryonic in vitro le micro. mekhoa ea ho qhekella.Ke eena rasaense oa pele le hona joale feela ea eketsang sekhahla sa tsoalo ea litoeba tse tsoang ho theknoloji ea matšeliso ea tetraploid ho tloha ho 1-5% ho ea ho 30-60% ka ho ntlafatsa, ho finyella indasteri ea theknoloji.O ngotse hammoho lipampiri tse 79 tsa SCI tse nang le tšusumetso e kopaneng ea 670 le litemana tse fetang 7150 mme o phatlalalitse likoranteng tse holimo tsa machabeng joalo ka Nature, Cell stem cell, jj.

Bakeng sa tlatsetso ea hae e babatsehang ho qhekelloeng ha lesea, lebitso la Dr. Wu le lula le behiloe ho Munich's Deutsches Museum, e leng musiamo o moholo ka ho fetisisa lefatšeng oa saense le theknoloji.

Ka Phato 2019, Dr. Wu o ile a tsebisoa Chaena e le mofuputsi oa nako e tletseng, eena le sehlopha sa hae sa lipatlisiso ba atlehile ho haha ​​​​moetso oa toeba oa ACE2 nakong ea matsatsi a 35, ba rala "motheo" oa liteko bakeng sa lipatlisiso tsa COVID-19 pathogenesis, tlhahlobo ea lithethefatsi, le ntlafatso ea ente.Ka lebaka la katleho ea hae e ntle ho saense le thekenoloji, Dr. Wu o ile a fuoa "Advanced Individual in Fighting against COVID-19 Profinseng ea Guangdong" ka 2020.

Khatelo-pele e atlehileng le ts'ebeliso ea theknoloji e tsoetseng pele ea Tetraploid Complementation (theknoloji ea TurboMice™) ea ho etsa litoeba nakong ea ntoa khahlanong le COVID-19, e khothaletsa Dr. Wu ho ikitlaelletsa ho fumana boleng bo boholo nts'etsopele ea biopharmaceuticals.Ka hona, o thehile Guangzhou MingCeler Biotech Co., Ltd joalo ka rasaense ea ka sehloohong, ea ikemiselitseng ho fetola theknoloji ea TurboMice ™ ho tloha laboratoring ho isa lits'ebetsong tsa indasteri ho fana ka lihlahisoa le litšebeletso tsa litoeba tsa maemo a holimo bakeng sa liunivesithi tsa lefats'e, litsi tsa lipatlisiso, lipetlele, le lik'hamphani tsa meriana tse amehang lipatlisisong tsa bophelo bo botle ba bophelo.